Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Oxidative imbalance is one of the earliest manifestations of Alzheimer disease (AD) actually preceding the classic pathology of amyloid β deposits and neurofibrillary tangles. Clinical trials examining antioxidant modulation by a number of global interventions show efficacy, while simple supplementation has limited benefit suggesting complexity of multiple contributing factors. In this review, we highlight new insights regarding novel approaches to understanding and treating AD based on holistic views of oxidative balance including diet.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · cited 1×
“Altered mitochondrial function, Aβ peptides, and the presence of trace metal ions such as iron and copper, have been identified as potential sources of oxidative stress (10-12).”
BackgroundMitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367 · cited 1×
“This has been shown in studies of AD patients as well as in transgenic mice overexpressing AβPP (11, 13-16).”
BackgroundSelf-citationConsumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.940 · Cited by 1,135 · cited 1×
“Fish consumption and diets rich in Omega-3 fatty acids have also been correlated with a lower risk of AD development (30).”
BackgroundManczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104 · cited 1×
“This has been shown in studies of AD patients as well as in transgenic mice overexpressing AβPP (11, 13-16).”
BackgroundReddy, P. H., & Beal, M. F. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.002 · Cited by 975
Intramuscular desferrioxamine in patients with Alzheimer's disease
MCLACHLAN, D. (1991) · The Lancet · doi:10.1016/0140-6736(91)92978-b · Cited by 764
Morris, M. C. (2002) · JAMA · doi:10.1001/jama.287.24.3230 · Cited by 678 · cited 1×
“This relationship, however does not exist for supplement only intake (29).”
Background
Cited by
Chen, Z., & Zhong, C. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.004 · Cited by 673
The antioxidant paradox: less paradoxical now?
Halliwell, B. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04272.x · Cited by 318
Oxidative stress, protein modification and Alzheimer disease
Tramutola, A., Lanzillotta, C., Perluigi, M., & Butterfield, D. A. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.06.005 · Cited by 303
“In addition to impaired mitochondrial function, Aβ peptides and the presence of trace metal ions such as iron and copper, have been identified as potential sources of OS [16, 31, 66].”
Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging
Fournet, M., Bonté, F., & Desmoulière, A. (2018) · Aging and disease · doi:10.14336/ad.2017.1121 · Cited by 291
Edaravone alleviates Alzheimer’s disease-type pathologies and cognitive deficits
Jiao, S.-S., Yao, X.-Q., Liu, Y.-H., Wang, Q.-H., Zeng, F., Lu, J.-J., Liu, J., Zhu, C., Shen, L.-L., Liu, C.-H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422998112 · Cited by 174
“It is well recognized that the formation of NFT is a down-stream event of Aβ toxicity that is caused by Tau hyperphosphorylation triggered by Aβ-induced activation of several kinases such as Cdk5 (36), GSK3β (37) and PKA (37).”
BackgroundBarone, E., Di Domenico, F., Mancuso, C., & Butterfield, D. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.018 · Cited by 127
Impaired Plasmalogens in Patients with Schizophrenia
Kaddurah-Daouk, R., McEvoy, J., Baillie, R., Zhu, H., K. Yao, J., Nimgaonkar, V. L., Buckley, P. F., Keshavan, M. S., Georgiades, A., & Nasrallah, H. A. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.02.019 · Cited by 89
“Both Alzheimer's disease (Clark et al., 2010) and schizophrenia (Mahadik et al.”
Background
Metadata
- Authors
- UTSA Neurosciences Institute and Department of Biology, C. O. S., Perry, G., Lee, H.-G., Lee, H. P., Zhu, X., Smith, M. A., Department of Pathology, C. W. R. U., Rolston, R. K., Geisinger Medical Center, D., Marlatt, M. W., Swammerdam Institute for Life Sciences - Center for Neuroscience, U. O. A., Castellani, R. J., Department of Pathology, U. O. M., Nunomura, A., Department of Neuropsychiatry, I. G. S. O. M. A. E., Casadesus, G., Department of Neurosciences, C. W. R. U., Clark, T. A., & UTSA Neurosciences Institute and Department of Biology, C. O. S.
- Venue
- International Journal of Biomedical Science
- Published
- 2010-09-15
- Volume
- 6
- Issue
- 3
- Pages
- 225-227
- ISSN
- 1550-9702 (ISSN-L)
- 1555-2810
- OpenAlex
- W4386988128
- Cited by
- 81
- References
- 7
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.